Open Access. Powered by Scholars. Published by Universities.®

Law Commons

Open Access. Powered by Scholars. Published by Universities.®

Selected Works

None

2013

Mary Ann Chirba

Articles 1 - 5 of 5

Full-Text Articles in Law

Moderator, "New Regulatory Models Ensuring Safety And Accelerating Treatments", Mary Ann Chirba Dec 2013

Moderator, "New Regulatory Models Ensuring Safety And Accelerating Treatments", Mary Ann Chirba

Mary Ann Chirba

No abstract provided.


Health Care Reform: Law And Practice, Mary Ann Chirba, Alice Noble, Michael Maddigan Oct 2013

Health Care Reform: Law And Practice, Mary Ann Chirba, Alice Noble, Michael Maddigan

Mary Ann Chirba

On March 23, 2010, President Obama signed comprehensive health reform, the Patient Protection and Affordable Care Act (PPACA) and commonly referred to as "Obamacare" or the Affordable Care Act (ACA), into law. With the passage of the ACA, Congress put an end to the century-long quest to secure coverage for all Americans facing steadily rising costs for increasingly sophisticated health care. In closing the book on that struggle, however, the law opened another. Health Care Reform: Law and Practice is designed to assist health care and legal professionals who need to understand what the law says, how it works, and …


Evolving Global Regulation Of Adult Stem Cell Therapies And Technologies, Mary Ann Chirba Oct 2013

Evolving Global Regulation Of Adult Stem Cell Therapies And Technologies, Mary Ann Chirba

Mary Ann Chirba

No abstract provided.


In Search Of Regulatory Consistency: The Role Of Ivf Regulations In Improving Fda Oversight Of Autologous Stem Cell Therapies, Mary Ann Chirba Feb 2013

In Search Of Regulatory Consistency: The Role Of Ivf Regulations In Improving Fda Oversight Of Autologous Stem Cell Therapies, Mary Ann Chirba

Mary Ann Chirba

No abstract provided.


Regulation Vs. The Practice Of Medicine, Mary Ann Chirba Feb 2013

Regulation Vs. The Practice Of Medicine, Mary Ann Chirba

Mary Ann Chirba

Professor Chirba presented on the impact of federal and cross-border regulation on the development and delivery of adult stem cell therapies and other emerging forms of regenerative medicine. She also participated on a panel of researchers and clinicians to discuss practical strategies for attaining regulatory reform.